Joanne B Weidhaas

Joanne B Weidhaas

UNVERIFIED PROFILE

Are you Joanne B Weidhaas?   Register this Author

Register author
Joanne B Weidhaas

Joanne B Weidhaas

Publications by authors named "Joanne B Weidhaas"

Are you Joanne B Weidhaas?   Register this Author

53Publications

1035Reads

10Profile Views

Identifying MicroRNA Pathway Variants as Biomarkers of Patient Selection for Immune Therapy.

Methods Mol Biol 2020 ;2055:203-212

Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9773-2_9DOI Listing
January 2020

The KRAS-variant and its impact on normal breast epithelial cell biology.

Cell Death Differ 2019 Dec 1;26(12):2568-2576. Epub 2019 Apr 1.

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41418-019-0320-y
Publisher Site
http://dx.doi.org/10.1038/s41418-019-0320-yDOI Listing
December 2019

Breast Cancer and miR-SNPs: The Importance of miR Germ-Line Genetics.

Noncoding RNA 2019 Mar 20;5(1). Epub 2019 Mar 20.

Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ncrna5010027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468861PMC
March 2019

Functional microRNA binding site variants.

Mol Oncol 2019 01 26;13(1):4-8. Epub 2018 Dec 26.

Department of Radiation Oncology, UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1878-0261.12421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322190PMC
January 2019

MicroRNA signatures discriminate between uterine and ovarian serous carcinomas.

Hum Pathol 2018 06 5;76:133-140. Epub 2018 Mar 5.

Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177183007
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2018.02.019DOI Listing
June 2018

The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality.

Cancer 2018 04 26;124(8):1673-1681. Epub 2018 Feb 26.

Department of Radiation Oncology, University of California at Los Angeles, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31159DOI Listing
April 2018

Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.

Breast Cancer Res Treat 2017 Nov 12;166(1):145-156. Epub 2017 Jul 12.

Department of Radiation Oncology, University of California, Los Angeles, 1223 16th Street, Suite 1100, Santa Monica, CA, 90404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4392-4DOI Listing
November 2017

The Non-Coding RNA Journal Club: Highlights on Recent Papers-4.

Noncoding RNA 2016 Sep 21;2(3). Epub 2016 Sep 21.

Department of Radiation Oncology, UCLA David Geffen School of Medicine, Professor, Director, Translational Research, Los Angeles, California 90024, USA..

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ncrna2030009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831907PMC
September 2016

Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9.

Noncoding RNA 2016 09 30;2(4). Epub 2016 Sep 30.

Department of Radiation Oncology, UCLA David Geffen School of Medicine, Professor, Director, Translational Research, Los Angeles, California 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ncrna2040010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831929PMC
September 2016

miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.

Nat Commun 2016 Mar 21;7:10954. Epub 2016 Mar 21.

Department of Radiation Oncology, David Geffen School of Medicine, Los Angeles, California 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms10954DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802117PMC
March 2016

Tumor-associated mutations in a conserved structural motif alter physical and biochemical properties of human RAD51 recombinase.

Nucleic Acids Res 2015 Jan 24;43(2):1098-111. Epub 2014 Dec 24.

Department of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405, USA Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, VT 05405, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gku1337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333388PMC
January 2015

Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.

Cell Cycle 2014 3;13(6):1030-40. Epub 2014 Feb 3.

Department of Molecular, Cellular, and Developmental Biology; Yale University; New Haven, CT USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.27941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984301PMC
October 2014

SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers.

Crit Rev Oncog 2013 ;18(4):327-40

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028830PMC
http://dx.doi.org/10.1615/critrevoncog.2013007254DOI Listing
June 2013

A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer.

Int J Radiat Oncol Biol Phys 2013 Jan 1;85(1):40-6. Epub 2012 Jun 1.

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.03.025DOI Listing
January 2013

SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer.

Pharmacol Ther 2013 Jan 3;137(1):55-63. Epub 2012 Sep 3.

Department of Therapeutic Radiology, Yale School of Medicine, 15 York Street, Hunter Building, HRT-205, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01637258120018
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2012.08.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546232PMC
January 2013

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.

Proc Natl Acad Sci U S A 2012 Jun 8;109(26):E1695-704. Epub 2012 Jun 8.

Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1201516109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387084PMC
June 2012

A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis.

EMBO Mol Med 2012 Mar 3;4(3):206-17. Epub 2012 Feb 3.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/emmm.201100200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376847PMC
March 2012

KRAS alleles: the LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel.

Cell Cycle 2012 Jan 15;11(2):361-6. Epub 2012 Jan 15.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.11.2.18794DOI Listing
January 2012

A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.

Clin Cancer Res 2011 Dec 12;17(24):7723-31. Epub 2011 Oct 12.

Departments of Pathology and Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0990DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919188PMC
December 2011

Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.

Cancer Biol Ther 2011 Nov 15;12(10):908-14. Epub 2011 Nov 15.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.12.10.17681DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280906PMC
November 2011

KRAS rs61764370 in Epithelial Ovarian Cancer-Letter.

Clin Cancer Res 2011 Oct;17(20):6600; author reply 6601

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1195DOI Listing
October 2011

miRNAs in the spotlight: Making 'silent' mutations speak up.

Nat Med 2011 Aug 4;17(8):934-5. Epub 2011 Aug 4.

Yale University School of Medicine Department of Therapeutic Radiology, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0811-934DOI Listing
August 2011

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.

Mol Ther 2011 Jun 22;19(6):1116-22. Epub 2011 Mar 22.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2011.48DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129804PMC
June 2011

MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Mol Diagn Ther 2010 Dec;14(6):335-42

Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf03256390DOI Listing
December 2010

MicroRNA signatures differentiate uterine cancer tumor subtypes.

Gynecol Oncol 2010 Sep 9;118(3):251-7. Epub 2010 Jun 9.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918705PMC
September 2010

MicroRNA binding site polymorphisms as biomarkers of cancer risk.

Expert Rev Mol Diagn 2010 Sep;10(6):817-29

Yale University School of Medicine, 15 York Street, New Haven, CT 06510 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erm.10.59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832135PMC
September 2010

MicroRNA in cancer prognosis.

N Engl J Med 2008 Dec;359(25):2720-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe0808667DOI Listing
December 2008

miRNA modulation of the cellular stress response.

Future Oncol 2008 Apr;4(2):289-98

Yale University, Department of Molecular, Cellular and Developmental Biology, PO Box 208103, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.4.2.289DOI Listing
April 2008

The let-7 microRNA reduces tumor growth in mouse models of lung cancer.

Cell Cycle 2008 Mar 3;7(6):759-64. Epub 2008 Mar 3.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cc.7.6.5834
Publisher Site
http://dx.doi.org/10.4161/cc.7.6.5834DOI Listing
March 2008

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

Cancer Res 2007 Dec;67(23):11111-6

Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar Street, P. O. Box 208040, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-2858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070379PMC
December 2007

A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in Radelegans.

Cancer Res 2006 Nov;66(21):10434-8

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-2182DOI Listing
November 2006

MicroRNAs as a potential magic bullet in cancer.

Future Oncol 2006 Feb;2(1):73-82

Yale University, Department of Molecular, Cellular and Developmental Biology, PO Box 208103, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.2.1.73DOI Listing
February 2006